We are a leading manufacturer of high-purity GLP-1 intermediates and monodisperse PEG derivatives based in China, specializing in fatty acid side chains, dipeptides, tetrapeptides, and PEG (n=8, 12, 24) derivatives. We are the No.1 supplier of fatty acid side chains for Semaglutide and Tirzepatide in China by market share, and are globally recognized for producing the highest-purity monodisperse PEGs.

Our strengths:
•	Strong R&D and manufacturing capabilities: 200-person R&D team, $25 million invested in advanced R&D instrumentation (including multiple 600 MHz NMRs and high-resolution MS), and a 33,000 m² GMP factory.
•	Industry-leading impurity control: single impurity <0.10% for key side chains; chain length variants <0.10% in PEG8, <0.15% in PEG12, and <0.40% in PEG24.
•	Competitive Cost: Achieved through process innovation and continuous optimization for highly efficient and simplified synthesis and purification.
•	Reliable supply: single-batch production >300 kg with inventory >100 kg for key side chains.
•	Comprehensive quality support: Full analytical method packages, impurity profiling studies, and reference standards available for all products.
•	Rapid customization: Accelerated synthesis of tailored side chains, PEG derivatives and GLP-1 building blocks to meet urgent project timelines
•	Green chemistry: Solvent usage minimized through optimized synthesis routes

Our GMP-compliant manufacturing and strong R&D capabilities ensure consistent quality and rapid response to client needs. Trusted by leading pharmaceutical companies and CDMO partners worldwide.

Inquiry: sales@csmspharm.com

Morning Shine Pharma

Org chart

Teams

Offices

Morning Shine Pharma

Org chart

Teams

Offices

Related companies